ubenimex has been researched along with Cancer of Gastrointestinal Tract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miwa, H; Oka, T; Orita, K; Sakae, Y; Tsurumi, T | 1 |
| Itoi, S; Kobayashi, M; Kohnosu, H; Kubo, H; Matsuda, A; Naito, K; Oka, T; Ueda, Y; Yamagishi, H | 1 |
2 other study(ies) available for ubenimex and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
[Experimental and clinical studies of bestatin as an immunomodulator].
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Colony-Forming Units Assay; Gastrointestinal Neoplasms; Hematopoietic Stem Cells; Immunity, Cellular; Leucine; Lymphocyte Activation; Male; Mice | 1982 |
Bestatin administration and the change in cellular immunity.
Topics: Antibiotics, Antineoplastic; Gastrointestinal Neoplasms; Humans; Immunity, Cellular; Intradermal Tests; Leucine; Lymphocyte Activation; Receptors, Interleukin-2; T-Lymphocyte Subsets | 1991 |